Mutations

SORL1 Y1816Y

Overview

Clinical Phenotype: Alzheimer's Disease
Position: (GRCh38/hg38):Chr11:121614899 T>C
Position: (GRCh37/hg19):Chr11:121485608 T>C
dbSNP ID: rs150315143
Coding/Non-Coding: Coding
DNA Change: Substitution
Expected Protein Consequence: Silent
Codon Change: TAT to TAC
Reference Isoform: SORL1 Isoform 1 (2214 aa)
Genomic Region: Exon 41

Findings

One Alzheimer’s case and seven controls were heterozygous carriers of this synonymous variant in a Dutch sample of 640 AD cases and 1268 controls. No additional carriers were found in a pan-European cohort of 1255 cases and 1938 controls from the European Early Onset Dementia Consortium (Holstege et al., 2017).

The Y1816Y variant is classified as benign by the criteria of Holstege et al. (Holstege et al., 2017).

Last Updated: 18 Jul 2024

Comments

No Available Comments

Make a Comment

To make a comment you must login or register.

References

Paper Citations

  1. . Characterization of pathogenic SORL1 genetic variants for association with Alzheimer's disease: a clinical interpretation strategy. Eur J Hum Genet. 2017 Aug;25(8):973-981. Epub 2017 May 24 PubMed.

Further Reading

No Available Further Reading

Protein Diagram

Primary Papers

  1. . Characterization of pathogenic SORL1 genetic variants for association with Alzheimer's disease: a clinical interpretation strategy. Eur J Hum Genet. 2017 Aug;25(8):973-981. Epub 2017 May 24 PubMed.

Other mutations at this position

Disclaimer: Alzforum does not provide medical advice. The Content is for informational, educational, research and reference purposes only and is not intended to substitute for professional medical advice, diagnosis or treatment. Always seek advice from a qualified physician or health care professional about any medical concern, and do not disregard professional medical advice because of anything you may read on Alzforum.